Nusrath Sultana is VP, Clinical Affairs of SURMODICS INC. Currently has a direct ownership of 6,530 shares of SRDX, which is worth approximately $256,824. The most recent transaction as insider was on Feb 12, 2022, when has been sold 762 shares (Common Stock) at a price of $41.67 per share, resulting in proceeds of $31,753. This information was disclosed in a Form 4 filing with the Securities and Exchange Commission (SEC).

Shares Held (Direct Ownership) 6.53K
0% 3M change
0% 12M change
Total Value Held $256,824

Nusrath Sultana Transaction History

Date Transaction Value Shares Traded Shares Held Form
Feb 12 2022
SELL
Payment of exercise price or tax liability
$31,753 $41.67 p/Share
762 Reduced 10.45%
6,530 Common Stock
Nov 30 2021
SELL
Payment of exercise price or tax liability
$18,934 $43.93 p/Share
431 Reduced 6.33%
6,382 Common Stock
Nov 30 2021
BUY
Grant, award, or other acquisition
-
910 Added 11.09%
7,292 Common Stock
Feb 12 2021
SELL
Payment of exercise price or tax liability
$23,873 $53.17 p/Share
449 Reduced 6.4%
6,566 Common Stock
Nov 30 2020
BUY
Grant, award, or other acquisition
-
3,739 Added 34.77%
7,015 Common Stock
NS

Nusrath Sultana

VP, Clinical Affairs
Eden Prairie, MN

Track Institutional and Insider Activities on SRDX

Follow SURMODICS INC and customize your updates to receive the information that matters most to you.

Institutional Portfolio Updates

Receive a notification when an Institution or Guru buys or sells SRDX shares.

Notify only if

Insider Trading

Get notified when an Surmodics Inc insider buys or sells SRDX shares.

Notify only if

News

Receive news related to SURMODICS INC

Track Activities on SRDX